Cancer Treatment Side Effect Research
Warriner was diagnosed with multiple myeloma in 2006 and, after induction chemotherapy, underwent autologous stem cell transplantation at MD Anderson. He eloquently shared his story at the colloquium and will soon present his experiences to [More]
Leukemia – Induction Therapy
Induction therapy (chemotherapy) for Acute Lymphoblastic Leukemia. Nicholas is 3.5 years old and tolerating treatment very well.
Monitoring the Microbiome in Leukemia Patients Could Reduce Infections During Chemotherapy
Jessica Galloway-Peña, Ph.D., fellow in the Department of Infectious Diseases, Infection Control and Employee Health at The University of Texas MD Anderson Cancer Center and her colleagues have shown that disruption of the microbiome by [More]
Is There a Role for Induction or Consolidation Chemotherapy Before/After Chemo/Radiation?
Dr. Nasser Hanna, Indiana University Health, considers the use of induction or consolidation chemotherapy for unresectable stage III NSCLC. http://cancergrace.org/lung/2016/03/14/gcvl_lu_induction_consolidation_chemotherapy_role/
Dr. James Melotek on Cetuximab/Chemotherapy Combinations in Head and Neck Cancer
James Melotek, MD, discusses the analysis of a recent phase II randomized trial looking into the combination of cetuximab with induction chemotherapy and accelerated or hyperfractionated chemoradiation therapy for locoregionally advanced head and neck cancer. [More]
Palliative Care Needed Alongside Aggressive Chemo
After leading a study that patients with acute myeloid leukemia who receive induction chemotherapy are quite distressed, Tom LeBlanc, hematologic malignancy specialist at Duke Cancer Institute, decided more palliative care should be offered alongside treatment for [More]
Monitoring the Microbiome in Leukemia Patients Could Reduce Infections During Chemotherapy
Jessica Galloway-Peña, Ph.D., fellow in the Department of Infectious Diseases, Infection Control and Employee Health at The University of Texas MD Anderson Cancer Center and her colleagues have shown that disruption of the microbiome by [More]
ASCO 2013: Dr. Burtness on Induction Chemo, Cetuximab + IMRT for HPV-Associated SCC
Barbara Burtness, MD, Fox Chase Cancer Center, discusses results of EKOG E 130 on induction chemo followed by cetuximab with low-dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the [More]
Dr. Melotek on Cetuximab Added to Chemotherapy and Chemoradiation in Head and Neck Cancer
James Melotek, MD, Radiation and Cellular Oncology, University of Chicago Medicine, discusses an analysis of a phase II study examining the addition of cetuximab to induction chemotherapy and accelerated or hyperfractionated chemoradiation therapy for locoregionally [More]